The present invention relates to a biomarker and method for identifying the subgroup of early stage lung adenocarcinoma patients in early stage NSCLC, which is helpful for {HEAD ~ the design} of clinical trials for {TAIL ~ adjuvant therapy} 
The present invention relates to a biomarker and method for identifying the subgroup of early stage lung adenocarcinoma patients in early stage NSCLC , which is helpful for { HEAD ~ the design } of clinical trials for { TAIL ~ adjuvant therapy }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL